Tacrolimus (FK-506) in kidney transplantation
- 1 February 1997
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2), 45-47
- https://doi.org/10.1016/s0041-1345(96)00007-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- THE RELATIVE EFFECTS OF FK506 AND CYCLOSPORINE ON SHORT- AND LONG-TERM KIDNEY GRAFT SURVIVAL1,2,3Transplantation, 1995
- REVERSAL OF STEROID-RESISTANT REJECTION IN RENAL ALLOGRAFT RECIPIENTS USING FK506Transplantation, 1995
- A PROSPECTIVE RANDOMIZED TRIAL OF FK506-BASED IMMUNOSUPPRESSION AFTER RENAL TRANSPLANTATION1Transplantation, 1995
- FK506 in pediatric kidney transplantation—Primary and rescue experiencePediatric Nephrology, 1995
- Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantationPediatric Nephrology, 1994
- FK506 “RESCUE” FOR RESISTANT REJECTION OF RENAL ALLOGRAFTS UNDER PRIMARY CYCLOSPORINE IMMUNOSUPPRESSION1Transplantation, 1994
- The Histopathological Changes Associated with Allograft Rejection and Drug Toxicity in Renal Transplant Recipients Maintained on FK506The American Journal of Surgical Pathology, 1993